Details of the Drug
General Information of Drug (ID: DM7HRLQ)
| Drug Name |
212Pb-TCMC-trastuzumab
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Lead212-labeled trastuzumab (cancer), AREVA/NCI; Radioimmunotherapeutic-212Pb (cancer), AREVA/NCI; Radioimmunotherapeutic-lead212 (cancer), AREVA/NCI | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Monoclonal antibody
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
